Bank of America’s GeoVax Labs GOVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-11
Closed -$45 6192
2025
Q4
$45 Sell
11
-17
-61% -$187 ﹤0.01% 6978
2025
Q3
$335 Buy
28
+3
+12% +$52 ﹤0.01% 7653
2025
Q2
$550 Buy
25
+22
+733% +$548 ﹤0.01% 7650
2025
Q1
$86 Hold
3
﹤0.01% 7861
2024
Q4
$190 Buy
3
+1
+50% +$58 ﹤0.01% 7598
2024
Q3
$104 Sell
2
-1,789
-100% -$150K ﹤0.01% 7716
2024
Q2
$143K Buy
+1,791
New +$78.7K ﹤0.01% 6063
2024
Q1
Hold
0
-$6 7910
2023
Q4
Hold
0
7838
2023
Q1
Sell
-1
Closed -$144 7983
2022
Q4
$144 Buy
+1
New +$304 ﹤0.01% 7610
2022
Q3
Hold
0
7985
2022
Q1
Hold
0
8441
2021
Q4
Hold
0
8371
2021
Q2
Sell
-7
Closed -$12K 7865
2021
Q1
$12K Buy
+7
New +$13.6K ﹤0.01% 6975
2020
Q4
Hold
0
7183

Other funds holding GOVX

Bank of America's GOVX Position: Q1 2026 in Review

Bank of America sold out of GeoVax Labs (GOVX) in Q1 2026, closing a stake of 11 shares — an estimated $45 sold.

Bank of America first reported a position in GOVX in Q1 2021 and held it in 9 quarters. The position peaked at $143K in Q2 2024. 16 funds tracked by Wall St. Rank hold GOVX as of Q1 2026.

  • Bank of America reported no remaining GeoVax Labs position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 11 GeoVax Labs shares in Q1 2026, an estimated $45.
  • Bank of America first reported a position in GeoVax Labs in Q1 2021 and held it in 9 quarters.
  • Bank of America's GeoVax Labs position peaked at $143K in Q2 2024.
  • 16 funds tracked by Wall St. Rank held GeoVax Labs as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.